business

Biotech Bubble Watch 2014

A correction could be in the offing

With valuations at historic highs, the industry’s bull run is looking frothy. Investors should brace for a correction, though not a 2000-like bust.

    Before it's here, it's on the Bloomberg Terminal. LEARN MORE